Wednesday, October 8, 2025

11:30 - 12:15

SEVERO OCHOA ROOM

---

Overview

Sponsor: LONZA

---

Details

Early-stage biologics offer transformative promise, and the right development strategy can unlock strong partnerships and sustainable funding. This session explores how founders, funders, and pharma partners can work together to translate innovation into fundable opportunities. Experts will share insights on scientific risk evaluation, milestone-driven funding, and trends shaping early-stage investment. Discover how shared goals, realistic timelines, and strategic planning can bridge the gap between vision and value and set the stage for successful exits and partnerships.

---

Details